AI system
- System
-
MediC and FiCRO
- Model
-
Not assessed
- Release
-
Not assessed
- Application developer
-
MEDIAIPLUS Inc.
- Role
-
Not assessed
- Configuration
-
Not assessed
- Inputs and outputs
-
Not assessed
- Autonomy
-
Not assessed
- Workflow
-
The account does not establish conditions sufficient to reproduce the benefit.
- Human oversight
-
Not assessed
- Relation to AI
-
The account does not isolate AI’s contribution from the surrounding workflow.
- AI contribution
-
Not assessed
Benefits
- Outcome identifiers
-
Not assessed
- Benefit
-
MEDIAIPLUS reports 85% less trial-data alignment time, 10% lower outsourcing costs, and a 25% improvement in trial success across early deployments.
- Category
-
Improved Organizational Efficiency
- Status
-
Reported and intended benefits
- Beneficiary groups
-
Organizations. People.
- Beneficiaries
-
Not assessed
- Reach
-
Not assessed
- Distribution and access
-
Not assessed
- Duration
-
Not assessed
- Expected?
-
Yes
- Costs and harms
-
Not assessed
Measurement
- Studies
-
Not assessed
- Study design
-
Not assessed
- Measurement
-
Not assessed
- Setting and sample
-
Not assessed
- Measures
-
Not assessed
- Comparison
-
Not assessed
- Results
-
Not assessed
- Additional value from AI
-
Not assessed
- Limitations
-
Not assessed
- Denominators
-
Not assessed
- Materials for replication
-
Not assessed
Money
- Kind of value
-
Not assessed
- Amount
-
Not assessed
- Currency and prices
-
Not assessed
- Period and unit
-
Not assessed
- Realization
-
Not assessed
- Recipients and payers
-
Not assessed
- Gross or net
-
Not assessed
- Included costs
-
Not assessed
- Comparison
-
Not assessed
- Method
-
Not assessed
- Return and payback
-
Not assessed
People and places
- Participants
-
Developer: MEDIAIPLUS Inc. Operator: Pilot partners including Blisstech.
- Jurisdictions
-
Benefit:
South Korea (pilots). - Ownership and control
-
Not assessed
- Dependencies
-
Not assessed
- Cross-border connections
-
Not assessed
- Geopolitical implications
-
Not assessed
Follow-up
- Conditions for replication
-
The account does not establish requirements for reproducing the benefit in other settings.
- Replication attempts
-
Not assessed
- Later findings
-
Not assessed
- Availability
-
Not assessed
- Institutional decision
-
Not assessed
- Grounds
-
Not assessed
- Action and result
-
Not assessed
- Success criterion
-
Not assessed
Evidence
- Source numbers
-
AIBD-0397-source-0001
- Citations
-
Numbered references below.
- Language
-
Not assessed
- Source relationships
-
Developer
- Original evidence
-
Not assessed
- Access and versions
-
Not assessed
- Supported findings
-
Not assessed
- Evidence links
-
Not assessed
- Evidence strength
-
Not assessed
- Missing evidence
-
Not assessed
Grades
- Assessed benefits
-
Organizations. People.
- Depth
-
Organizations: 2. People: Not assessed.
- Reasons
-
Organizations: MEDIAIPLUS reports 25% better trial success, 85% less data-alignment time, and 10% lower outsourcing costs across early deployments. Measurement details are unavailable. People: Faster access to therapy is inferred from trial preparation, not documented for a patient.
- Observed or intended
-
Reported and intended benefits
- Rubric
-
Not assessed
- Assessor and date
-
Not assessed
- Alternative assessments
-
Not assessed
- Fill
-
The makers' claim
Entry details
- Kind
-
Not assessed
- Related entries
-
Not assessed
- Field
-
Healthcare.
- Purpose
-
Streamline protocol planning and selection of clinical research partners.
- Dates
-
Source information as of: June 2025. Updated: 22 October 2026.
- Stage
-
Not assessed
- Version
-
SHA-256: 7d3ca1d3bca1…
References
- Other identifiers
-
ITU AI for Good: Innovate for Impact (2025). ITU-013.
- Category mappings
-
Not assessed
- Brief
-
Not assessed
- Revisions
-
1 revisions. Latest: 22 October 2026.